The T-cell receptor (TCR) determines the specificity of T-cell recognition by binding to peptide fragments of intracellular proteins presented at the cell surface in association with molecules of the major histocompatibility complex (MHC). Engagement of the TCR by its cognate peptide/MHC ligand, with appropriate co-stimulatory signals, leads to activation of T-cell effector functions. Here we show that the attachment proteins of attenuated measles viruses, engineered to display a high-affinity single-chain TCR (scTCR), can recognize and bind to specific peptide-MHC complexes and thereby mediate targeted virus-cell entry and cell-to-cell fusion. Using the 2C TCR and its peptide/MHC ligand (SIYRYYGL/mouse K b ), we show that a scTCR grafted onto the measles virus H protein confers new specificity to virus entry and cell fusion. The efficiency of TCR-mediated virus entry was dependent on the number of peptide/MHC complexes expressed on the target cells, increasing progressively above densities higher than 2500 complexes per cell. This work introduces a new paradigm for targeting virus entry and membrane fusion by extending the repertoire of targets to specific peptide-MHC ligands and offering a novel quantitative readout for the cellular expression of peptide-MHC complexes.
Introduction
The 10 4 -10 6 major histocompatibility complex (MHC) class I molecules displayed on the surface of most nucleated cells present a diverse array of antigenic peptides for surveillance by T-cell receptors. [1] [2] [3] The peptides are generated by proteosomal processing of intracellular proteins and are then transported to the endoplasmic reticulum for loading onto class I MHC molecules. 2 The repertoire of peptide/MHC complexes expressed on a given cell surface is extremely diverse; any one complex typically occurs at a frequency between ten and a few hundred copies per cell, but may increase to more than 10 4 in the case of neoplastic or virally infected cells. 3 In the presence of appropriate costimulatory signals, engagement of the T-cell receptor (TCR) by its cognate peptide/MHC ligand leads to activation of T-cell effector functions. 4, 5 Specific immunogenic peptide-MHC complexes have been well characterized in several autoimmune diseases, viral infections, and cancers, and therapies using genetically modified T cells or toxin-conjugated antibodies that target these peptide/MHC complexes are being developed. [6] [7] [8] To offer a new paradigm in targeting of peptide/MHC complexes, we engrafted a single-chain TCR (scTCR) 9, 10 onto the attachment (hemagglutinin, H) protein of attenuated Edmonston strain of measles virus (MV-Edm) and demonstrated peptide/MHC-restricted, TCR-dependent membrane fusion.
Measles virus is a negative-strand RNA virus, which enters cells through binding to either of two cellular receptors, CD46 or SLAM (signaling lymphocyte activation molecule) via its H attachment protein. 11, 12 H proteinmediated attachment induces a conformational rearrangement of the viral fusion protein (F), thereby triggering membrane fusion. Cellular expression of viral H and F proteins leads to extensive cell fusion, leading to the formation of giant multinucleated syncytia that are nonviable. Attenuated measles viruses were recently reported to have potent and selective oncolytic activity against human tumor xenografts [13] [14] [15] [16] and the host range properties of the virus were successfully modified by display of polypeptide ligands at the C-terminus of the H protein. [17] [18] [19] [20] In light of its dual role in mediating both virus-cell and cell-cell fusion, the H protein of measles virus therefore provided an attractive platform for display of TCR to determine the feasibility of TCR-directed membrane fusion.
Results

Generation and characterization of the recombinant viruses
To determine if a functional scTCR could be displayed on measles virus, we constructed recombinant MV-Edms displaying low-or high-affinity versions of the same scTCR at the C-terminus of MV-H (Figure 1a ). Both the low-affinity T7 scTCR and the high-affinity m33 scTCR 21 were derived from the 2C TCR and recognize the agonist ligand SIYRYYGL (SIYR) in association with mouse K b with affinities of 30 mM and 30 nM, respectively. 10, 22, 23 Both viruses contain an additional transcription unit encoding enhanced green fluorescent protein (eGFP) upstream of the N (nucleoprotein) gene to facilitate recognition of virus-infected cells, and a FLAG tag at the N-terminus of H to facilitate detection of the chimeric H proteins. Viral incorporation of the chimeric scTCRdisplaying H proteins was evaluated by immunoblotting of sucrose-purified virions using an anti-FLAG antibody (Figure 1b) . The incorporation efficiency of the chimeric H proteins displaying the m33 scTCR or T7 scTCR was similar to the incorporation of unmodified H proteins in nonchimeric MV-eGFP virions. After correcting for H protein content, the CD46-dependent infectivities of the chimeric T7 scTCR and m33 scTCR viruses on African green monkey Vero cells were eight-fold higher compared to the parental virus MV-eGFP, suggesting that the displayed scTCRs do not compromise the fusion support function of the chimeric H proteins. Also, the one-step growth curves of the chimeric viruses on Vero cells (both cell associated and released virions) were comparable to the parental MV-eGFP virus, indicating that display of the T7 or m33 scTCRs did not impair the growth kinetics or the maximal titers of the chimeric viruses (Figure 1c) .
Targeted virus entry into peptide-loaded cells
To determine whether the scTCRs engrafted on the viral surface are able to mediate virus entry in an MHCrestricted manner, we loaded EL4 cells (H-2 b ) with the agonist peptide SIYR or a control peptide SIINFEKL (pOV8, chicken ovalbumin residues 257-264) 24 and infected them with parental MV-eGFP, MV-T7, MV-m33 or MV-CD38, a chimeric virus displaying a single-chain antibody (scFv) against the plasma cell marker CD38. (Figure 2b ). The ability of the m33 scTCR to mediate virus-cell entry through its cognate MHC/peptide complex was also confirmed using another H-2 b cell line, RMAS (data not shown). Comparison of the infectivities of the low-affinity MV-T7 virus and the higher affinity MV-m33 virus on SIYRloaded EL4 cells suggests that a high-affinity interaction between the displayed scTCR and its cognate peptide/ MHC complex is required to mediate significant virus entry. TCR/peptide/MHC affinities are usually in the micromolar range, but the requirement for a nanomolar interaction can be achieved by TCR affinity maturation using yeast 21 or possibly retrovirus 25 display libraries.
Targeted virus entry into cells presenting endogenous peptides in association with MHC
An appealing aspect of targeting measles virus through TCR display is that, unlike antibodies, TCRs recognize antigenic peptides derived from intracellular proteins that are not otherwise accessible at the cell surface. We therefore sought to determine if murine K b -positive cells that had not been loaded with exogenous SIYR peptide, but which express the peptide endogenously, could be recognized and infected by measles viruses displaying the m33 scTCR. We compared GFP positivity in EL4 cells that stably expressed the SIYR peptide (ETS-1 cells) or Targeted virus entry through a scTCR and its peptide/MHC complex K-W Peng et al the chicken ovalbumin (EG7-OVA cells) after infection with the various recombinant viruses. None of the viruses were able to infect the EG7-OVA cells and neither the MV-GFP nor the MV-T7 viruses could infect the ETS-1 cells (Figure 3a) . In contrast, the MV-m33 virus efficiently infected the ETS-1 cells causing a dramatic cytopathic effect with extensive cell-to-cell fusion caused by chimeric H proteins expressed on the surface of MVm33-infected cells interacting with cell surface SIYR/K b complexes on uninfected neighboring ETS-1 cells. To determine the infectious titer of the viruses on ETS-1 cells, a fusion inhibitory peptide (FIP, Z-D-Phe-Phe-Gly-OH) 26 that inhibits cell-to-cell fusion was added immediately after infection and, 24 h later, the number of GFP-positive cells was counted by flow cytometry (Figure 3b ). The number of infected ETS-1 cells was at least 10 000-fold higher for MV-m33 compared to either MV-eGFP or MV-T7. None of these viruses was able to infect parental EL4 cells (Figure 2a) , nor EL4 cells stably expressing the chicken ovalbumin (EG7-OVA) peptide (Figure 3a) . Infection of ETS-1 cells by MV-m33 increased from 0.5 to 99% as the viral dose increased and was inhibited by more than 90% in the presence of an anti-K b antibody that blocks the interaction of the displayed scTCR and its cognate peptide/MHC complex ( Figure  3c ). In contrast, even at the highest dose of virus that was tested (MOI 50), infection of the ETS-1 and EG7-OVA cells by the MV-eGFP and MV-T7 viruses remained very low, at background levels.
Number of peptide/MHC complexes required for virus entry
Receptor density is known to be a key factor in TCRtarget interactions. For example, it has been calculated that 200-400 peptide/MHC class II complexes per antigen-presenting cell are sufficient to induce a minimal response from a helper T cell, whereas maximum stimulation may occur at densities in excess of 5000 complexes per cell. 27 Likewise, for MHC class I restricted T cells, the number of complexes required for T-cell activation varies from about ten to a few thousand. 
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To determine the relationship between TCR-mediated virus entry and cell surface density of peptide/MHC complexes, EL4 cells were loaded with various concentrations of SIYR peptide and infected with MV-m33 virus. With increasing surface density of peptide/MHC molecules, the number of GFP-positive MV-m33-infected cells increases, indicating that virus entry through the scTCR interaction is peptide/MHC complex density dependent (Figure 4a and b) . To determine the number of peptide/MHC complexes required at the cell surface to mediate virus entry, we loaded EL4 cells with increasing concentrations of SIYR peptide and measured the corresponding number of peptide/MHC molecules on the cell surface at each peptide concentration using a soluble high-affinity TCR as a probe 28 ( Figure 4c) . By comparing the curves for peptide dose against virus entry and number of SIYR peptide/K b MHC complexes, we determined that, at 2 h after incubation, about 2500 peptide/MHC complexes per cell (5 Â 10 À7 M SIYR) were present on the cell surface at a concentration of SIYR (0.5 mM) sufficient for the MV-m33 virus to infect 25% of the cells at a low MOI of 2.0. At shorter (30 min) or longer time points (20 h), there was considerably less SIYR/K b expressed on EL4 cells (data not shown), indicating that infection may require even fewer than 2500 peptide/ MHC complexes per cell. This estimate of the number of peptide/MHC molecules required for TCR-mediated membrane fusion is comparable to that required for TCR-mediated activation of many T cells, 29 although the presence of appropriate T-cell co-receptors can stabilize the intercellular interaction and augment TCR-mediated signaling at lower peptide/MHC densities.
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Conclusions
Membrane fusion between viruses and cells or between adjacent cells can be triggered by various ligandreceptor interactions, but has never previously been reported as a consequence of the interaction between a TCR and its cognate MHC-peptide complex. Our findings therefore greatly expand the repertoire of cellular targets through which virus entry or cell fusion can be redirected. For other viral fusion proteins that have been engineered to display polypeptide ligands, the efficiency of fusion triggering has been drastically reduced after binding to the targeted receptors (eg murine leukemia virus, 32 influenza hemagglutinin, 33 Sindbis E1/E2 34 ). In contrast to this previous experience, the measles virus H/F system is highly versatile, allowing efficient receptor-targeted fusion through the display of growth factors, single-chain antibodies and, now, single-chain TCRs. Our data show that receptor density is an important determinant of TCR-mediated membrane fusion, such that increasing the number of SIYR/K b complexes on EL4 cells resulted in corresponding increases in both MV-m33 virus entry and cell-cell fusion. The ability to link the effector function of membrane fusion to a single-chain TCR will facilitate a number of novel applications, both as a research tool and as a basis for targeted therapies. Thus, TCR-targeted virus entry or cell fusion can provide a quantitative readout for the expression of peptide/MHC complexes. Opportunities also exist for the development of TCRtargeted measles viruses or F/H-expressing gene therapy vectors for selective destruction of tumors that express targetable peptide/MHC complexes.
Materials and methods
Generation of an EL4 line expressing endogenous SIYR (ETS-1)
The plasmid that contains the gene encoding SIYR peptide (VR1055-P16/SIYR) was kindly provided by Targeted virus entry through a scTCR and its peptide/MHC complex K-W Peng et al Drs Bryan Cho and Herman Eisen (MIT, Cambridge, MA, USA). VR1055-P16/SIYR expresses 16 tandem repeats of coding sequence for SIYR, each flanked on the 5 0 and 3 0 ends by residues corresponding to the proteolytic sites of defined peptides. 35 The murine thymoma EL4 was transfected with VR1055-P16/SIYR plasmid by electroporation, and transfectants were selected with puromycin at a concentration of 1 mg/ml, and cloned by limiting dilution. Clones that expressed endogenous SIYR peptide bound to K b were screened by staining of clones with soluble m67 TCR, 21 biotin-antiVb8 antibody F23.1, and phycoerythrin-streptavidin (PE-SA), followed by flow cytometry. A positive cell line called ETS-1 was identified, and maintained in RPMI 1640 media supplemented with 5 mM Hepes, 10% (v/v) fetal bovine serum, 1.3 mM L-glutamine, 50 mM 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml of streptomycin, and 1 mg/ml puromycin. In addition, ETS-1 was capable of stimulating IL-2 release from 2C T cells (unpublished data).
Cell culture
Vero cells were purchased from the American Type Culture Collection (ATCC) and grown in 5% FBS-DMEM. The EL4 T-cell lymphoma (H-2 b ), EL4 expressing chicken ovalbumin (E.G7.OVA, ATCC CRL 2113), EL4 expressing SIYRYYGL peptide (ETS-1), and P815 mastocytoma (H-2 d , ATCC TIB-64) cells were grown in 10% FBS-DMEM. The E.G7.OVA and ETS-1 cells were maintained under selection, respectively, in 0.4 mg/ml G418 or 0.5 mg/ml puromycin. Peptides SIYRYYGL (SIYR) and SIINFEKL (pOV8) were made at the Mayo Protein Synthesis Core.
Generation and characterization of recombinant viruses
The cDNA for the low-affinity scTCR (T7) or highaffinity scTCR (m33) were PCR amplified as Sfi1/Not1 fragments and inserted as in-frame fusions linked to the C-terminus of MV-H to generate pCGHT7 or pCGHm33. The H gene contains a FLAG tag (single amino-acid code: DYKDDDDK) at the N-terminus to facilitate protein detection. The recombinant H glycoproteins were cloned as Pac1/Spe1 fragments into the full-length infectious clone of MV-eGFP. 36 Recombinant viruses were rescued using the standard MV rescue system 37 and characterized as follows. One-step growth curves of MV-eGFP, MV-T7, and MV-m33 on Vero cells were obtained by infecting a monolayer of Vero cells (plated overnight at a density of 2 Â 10 5 cells/six-well plate) at an MOI of 3.0 for 2 h at 371C. The virus inoculum was removed and the medium (1 ml) was replaced and the cells incubated at 321C. At various time points post infection, the medium (released virions) was collected and cells were harvested (cell-associated virions) into 1 ml Opti-MEM (Gibco), frozen and thawed for two cycles and viral titers were determined by TCID50 titration on Vero cells. For immunoblotting, conditioned medium was harvested from infected Vero cells, centrifuged to remove cellular debris and viral particles were concentrated and purified through a 20-60% sucrose gradient as described previously. 18 The purified virions were dissolved in 100 ml Opti-MEM and titrated on Vero cells. In all, 1 Â 10 5 or 8 Â 10 5 pfu of virus particles were loaded and viral proteins were then separated on a 7.5% SDS-PAGE gel, electrotransferred to nitrocellulose membrane (Amersham) and immunoblotted using an anti-Flag antibody conjugated to HRP at 1:2000 dilution (Sigma Chemicals). The proteins were detected using a chemiluminescence kit (Pierce). The total number of SIYR/K b complexes on EL4 after incubation with synthetic SIYR peptide or on ETS-1 was determined with the soluble m67 TCR as a probe. To determine the maximum number of SIYR/K b molecules on EL4, EL4 cells and T2-K b cells were pulsed with a saturating concentration of SIYR peptide for 2 h at 371C. After washing, cells were stained with soluble m67 TCR, followed by biotin-F23.1, and PE-SA. The mean PE fluorescence units (MFU) were determined using flow The numbers of SIYR/K b molecules expressed on EL4 at various SIYR concentrations, and on the ETS-1 line, were calculated from MFU values determined after staining with the soluble m67 TCR, using 28 500 molecules as the maximum at saturating SIYR concentrations.
Specificity assays
EL4 (H-
